NVDA stock · SER stock

NVDA vs SER · P/E 58, rev $96.22B vs rev $56.0K

NVIDIA Corporation (NVDA) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.

NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.

Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.

Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.

Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.

NVDA currently screens at market cap $4.40T and trailing P/E 58.2. SER currently screens at market cap $29.7M.

Not investment advice. Open the NVDA and SER stock pages for the full models.

Not investment advice.

Popular Stock Comparisons